Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy

Antibody-based cancer immunotherapy has become a powerful asset in the arsenal against malignancies. In this regard, bispecific antibodies (BsAbs) are a ground-breaking novel approach in the therapy of cancers. Recently, BsAbs have represented a significant advancement in improving clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhangnia, Pooya, Ghomi, Shamim Mollazadeh, Akbarpour, Mahzad, Delbandi, Ali-Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333476/
https://www.ncbi.nlm.nih.gov/pubmed/37441075
http://dx.doi.org/10.3389/fimmu.2023.1155778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333476/
https://www.ncbi.nlm.nih.gov/pubmed/37441075
http://dx.doi.org/10.3389/fimmu.2023.1155778

Ejemplares similares